KURA
Price
$9.37
Change
+$0.16 (+1.74%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
814.48M
47 days until earnings call
Intraday BUY SELL Signals
TCRX
Price
$1.20
Change
+$0.03 (+2.56%)
Updated
Jan 14 closing price
Capitalization
68.1M
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KURA vs TCRX

Header iconKURA vs TCRX Comparison
Open Charts KURA vs TCRXBanner chart's image
Kura Oncology
Price$9.37
Change+$0.16 (+1.74%)
Volume$27.35K
Capitalization814.48M
TScan Therapeutics
Price$1.20
Change+$0.03 (+2.56%)
Volume$487.62K
Capitalization68.1M
KURA vs TCRX Comparison Chart in %
KURA
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KURA vs. TCRX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KURA is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (KURA: $9.36 vs. TCRX: $1.20)
Brand notoriety: KURA and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KURA: 51% vs. TCRX: 67%
Market capitalization -- KURA: $814.48M vs. TCRX: $68.1M
KURA [@Biotechnology] is valued at $814.48M. TCRX’s [@Biotechnology] market capitalization is $68.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KURA’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • KURA’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both KURA and TCRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 2 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • KURA’s TA Score: 2 bullish, 6 bearish.
  • TCRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than KURA.

Price Growth

KURA (@Biotechnology) experienced а -6.12% price change this week, while TCRX (@Biotechnology) price change was +1.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

KURA is expected to report earnings on Mar 03, 2026.

TCRX is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($814M) has a higher market cap than TCRX($68.1M). TCRX YTD gains are higher at: 17.000 vs. KURA (-11.357). TCRX has higher annual earnings (EBITDA): -136.89M vs. KURA (-212.24M). KURA has more cash in the bank: 550M vs. TCRX (184M). KURA has less debt than TCRX: KURA (19.5M) vs TCRX (95.6M). KURA has higher revenues than TCRX: KURA (104M) vs TCRX (8.42M).
KURATCRXKURA / TCRX
Capitalization814M68.1M1,195%
EBITDA-212.24M-136.89M155%
Gain YTD-11.35717.000-67%
P/E RatioN/AN/A-
Revenue104M8.42M1,235%
Total Cash550M184M299%
Total Debt19.5M95.6M20%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KURATCRX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 6 days ago
77%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 29 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KURA
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IARAX16.140.11
+0.69%
Invesco Real Estate A
ALSCX8.120.01
+0.12%
Alger Small Cap Growth B
RPMIX9.82N/A
N/A
Royce Small-Cap Fund Instl
WGUSX13.97-0.03
-0.21%
Wasatch US Select Inst
WSTRX52.08-0.15
-0.29%
Nomura Science and Technology R

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
+0.44%
XNCR - KURA
59%
Loosely correlated
-1.62%
CLDX - KURA
56%
Loosely correlated
+1.01%
VYGR - KURA
55%
Loosely correlated
+3.08%
NRIX - KURA
55%
Loosely correlated
+2.99%
IMNM - KURA
54%
Loosely correlated
-2.09%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with BMEA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
N/A
BMEA - TCRX
38%
Loosely correlated
+4.11%
BEAM - TCRX
38%
Loosely correlated
+2.55%
MGNX - TCRX
37%
Loosely correlated
-2.23%
KURA - TCRX
36%
Loosely correlated
+0.44%
XNCR - TCRX
36%
Loosely correlated
-1.62%
More